| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Niki BioSolutions (NASDAQ:NIKI) through any online brokerage.
Other companies in Niki BioSolutions’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Niki BioSolutions to provide a consensus price target.
The stock price for Niki BioSolutions (NASDAQ: NIKI) is $3.51 last updated October 9, 2026 at 6:56 PM EDT.
There are no upcoming dividends for Niki BioSolutions.
Niki BioSolutions does not have any upcoming earnings scheduled.
There is no upcoming split for Niki BioSolutions.
Niki BioSolutions is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Niki BioSolutions Inc, formerly Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in...